Anti-remodeling potencies of the soluble guanylate cyclase activator BAY 41-2272 in human lung fibroblasts

被引：0
|
作者：
Lambers, Christopher
Roth, Michael
Hofbauer, Elisabeth
Petkov, Venzel
Block, Lutz-Henning
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Pulmonary hypertension; Cell biology; Idiopathic pulmonary fibrosis;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3423
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Oxidative Stress Impairs Vasorelaxation Induced by the Soluble Guanylyl Cyclase Activator BAY 41-2272 in Spontaneously Hypertensive Rats
    Priviero, Fernanda B. M.
    Zemse, Saiprasad M.
    Teixeira, Cleber E.
    Webb, R. Clinton
    AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 (05) : 493 - 499
  • [22] Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure
    Boerrigter, G
    Costello-Boerrigter, LC
    Cataliotti, A
    Tsuruda, T
    Harty, GJ
    Lapp, H
    Stasch, JP
    Burnett, JC
    CIRCULATION, 2003, 107 (05) : 686 - 689
  • [23] Relaxing effects induced by the soluble guanylyl cyclase stimulator BAY 41-2272 in human and rabbit corpus cavernosum
    Baracat, JS
    Teixeira, CE
    Okuyama, CE
    Priviero, FBM
    Faro, R
    Antunes, E
    De Nucci, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 477 (02) : 163 - 169
  • [24] The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes
    Rosa, Irene
    Fioretto, Bianca Saveria
    Romano, Eloisa
    Buzzi, Matilde
    Mencucci, Rita
    Marini, Mirca
    Manetti, Mirko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [25] Soluble guanylate cyclase stimulator BAY41-2272 ameliorates cardiovascular remodeling in angiotensin imnduced hypertensive rats
    Masuyama, H
    Tsuruda, T
    Kato, J
    Imamura, T
    Asada, Y
    Stasch, JP
    Eto, T
    JOURNAL OF HYPERTENSION, 2005, 23 : S131 - S131
  • [26] Cardiorenal actions of the novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure in comparison to nitroglycerin
    Boerrigter, G
    Costello-Boerrigter, LC
    Lapp, H
    Cataliotti, A
    Tsuruda, T
    Harty, GJ
    Stasch, JP
    Burnett, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 253A - 254A
  • [27] The soluble guanylyl cyclase stimulator BAY 41-2272 increases differentiation and function of brown adipocytes
    Jennifer Etzrodt
    Linda S Hoffmann
    Andreas Friebe
    Alexander Pfeifer
    BMC Pharmacology and Toxicology, 14 (Suppl 1)
  • [28] Different sensitivities of soluble guanylyl cyclase isoforms towards the novel drug BAY 41-2272
    Koglin, M
    Behrends, S
    Scholz, H
    Stasch, JP
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R41 - R41
  • [29] The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide
    Roger, Severine
    Badier-Commander, Cecile
    Paysant, Jerome
    Cordi, Alex
    Verbeuren, Tony J.
    Feletou, Michel
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (05) : 1044 - 1058
  • [30] Novel soluble guanylyl cyclase stimulator BAY 41-2272 attenuates ischemia-reperfusion-induced lung injury
    Egemnazarov, Bakytbek
    Sydykov, Akylbek
    Schermuly, Ralph T.
    Weissmann, Norbert
    Stasch, Johannes-Peter
    Sarybaev, Akpai S.
    Seeger, Werner
    Grimminger, Friedrich
    Ghofrani, Hossein A.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2009, 296 (03) : L462 - L469
12345